Comparison Histamine-2 Receptor Antagonist & Antacid
Comparison Histamine-2 Receptor Antagonist & Antacid
Comparison Histamine-2 Receptor Antagonist & Antacid
Antacid
Histamine-2 Receptor Antagonist
Their onset is slower than that of antacids, but their duration is
longer.
In large heartburn studies the earliest onset of symptom relief
occurs around 30 minutes and peak effects are 1-1.5 hours after
treatment.
The anti-secretory effect, even with low doses, is prolonged and
lasts for around 10-12 hours. This means dosing frequency compared
to antacids can be reduced and many subjects require only one dose
per day.
Antacid
Acid in the oesophagus and stomach may be partly or completely
neutralised for rapid relief of symptoms but further gastric acid
production will occur and may be stimulated via a gastrin-mediated
response to a rise in gastric pH.
The consumption of further food will contribute to the termination
of activity as gastric acid production is stimulated.
By virtue of their mode of action, antacids cannot be used to
prevent symptoms associated with ‘trigger’ foods.
For these reasons antacids require regular re-dosing as
symptoms return.
HISTAMINE-2 RECEPTOR
ANTACIDS
ANTAGONISTS
(Magnesium Trisilicate)
(Ranitidine)
Mechanism of Inhibit acid secretion by Antacids can neutralize
Action blocking H2 receptors on the gastric acid and reduce acid
parietal cell delivery to the
duodenum. They may also
stimulate the defensive
systems in the stomach by
increasing bicarbonate and
mucus secretion.
Side Effects Side effects of H2RAs are Antacid side effects depend
rare upon the quantity consumed
and the duration of therapy.
A common side effect
associated with ranitidine is Magnesium-containing
headache, occurring in about antacids cause diarrhea and
3% of people who take it. hypermagnesemia; the latter
only becomes important in
Confusion: Rare cases of patients with renal
reversible confusion have insufficiency.
been associated with
ranitidine; usually elderly or Long-term, excessive use has
severely ill patients, or in been associated with the
patients with renal or hepatic development of silica-based
impairment. renal calculi.
References
1. https://www.uptodate.com.
2. http://www.kck.usm.my/husm/pharmacy/formulary/5.htm
#5a
3. https://www.uspharmacist.com/article/updates-in-
nonprescription-therapy-for-heartburn-and-gerd
4. https://www.ncbi.nlm.nih.gov/pubmed/8164599
5. http://selfcarejournal.com/article/self-care-of-heartburn/
6. https://www.drugs.com/ppa/ranitidine.htm
7. https://www.medicines.org.uk/emc/medicine/25289
8. http://www.nytimes.com/health/guides/disease/gastroesop
hageal-reflux-disease/medications.html
Posted by AskUsAtDis at 4:01 PM
Email ThisBlogThis!Share to TwitterShare to FacebookShare to Pinterest
Labels: Indication, others
1 comment:
1.